Glaucoma Outcomes Survey
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- La Crosse, Wisconsin: 20-010922
About this study
The purpose of this research study is to determine how useful a questionnaire, the Glaucoma Outcomes Survey (GOS), is as a tool for measuring patient quality of life after undergoing minimally invasive glaucoma surgery combined with cataract surgery.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patient 22 years or older at screening.
- Patient signed informed consent.
- Able to understand English (to complete survey without translation assistance).
- Determined to be a candidate for a planned MIGS device implantation procedure performed adjunctively with cataract surgery, as determined by the treating physician.
- Diagnosis of Mild to Moderate Glaucoma defined (Humphrey Visual Field - HVF at baseline) as:
Visual Field Mean Deviation (dB) Impairment Group
*Deviation more than - 2 through -6 (inclusive) | Mild
*Deviation more than - 6 through -12 (inclusive) | Moderate
Exclusion Criteria:
- Prior surgery for glaucoma, including MIGS, stent placement, or filtration surgery on study eye, the exception to this is that prior performance of laser trabeculoplasty is not an exclusion criterion.
Eligibility last updated 8/31/21. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
La Crosse, Wis.
Mayo Clinic principal investigator Nitika Arora, M.B.B.S. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available